Inventaire - your friends and communities are your best library

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

Published in: Nature

Date of publication: September 24, 1992

Language: English

Main subject: hemopoiesis, neurogenesis

Bibliographic databases:

Cites articles 39

Date

Title

Authors

March 1, 1970

Ontogeny of the haemopoietic system: yolk sac origin of in vivo and in vitro colony forming cells in the developing mouse embryo,Ontogeny of the Haemopoietic System: Yolk Sac Origin of In Vivo and In Vitro Colony Forming Cells in the Developing Mouse Embryo
April 1971

Mutation and cancer: statistical study of retinoblastoma
May 7, 1976

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
February 1, 1979

The electroencephalogram (EEG) as a research tool in human behavior genetics: psychological examinations in healthy males with various inherited EEG variants. I. Rationale of the study. Material. Methods. Heritability of test parameters
October 1, 1983

Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
November 1, 1984

Second nonocular tumors in retinoblastoma survivors. Are they radiation-induced?
October 1, 1986

Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas
October 1986

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
June 1, 1987

Structural evidence for the authenticity of the human retinoblastoma gene
March 1, 1987

Human retinoblastoma susceptibility gene: cloning, identification, and sequence
December 1, 1987

Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein
October 1987

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
January 1, 1987

Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter
November 6, 1987

Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
December 1, 1988

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
July 15, 1988

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
July 14, 1988

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product
November 24, 1988

Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes
September 1, 1989

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle
September 1, 1989

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
December 1, 1989

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
February 17, 1989

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
September 1, 1989

Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein
February 1, 1990

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.
February 1, 1990

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.
July 1990

Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
January 1, 1990

C-terminal truncation of the retinoblastoma gene product leads to functional inactivation
September 21, 1990

The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain
June 1, 1991

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells
October 1, 1991

The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
August 1, 1991

Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product
June 1, 1991

The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F

Article -

Welcome to inventaire

The library of your friends and communities

Learn more